Company Filing History:
Years Active: 1999
Title: The Innovations of William L. Perry, III
Introduction
William L. Perry, III is a notable inventor based in Salt Lake City, Utah. He has made significant contributions to the field of cancer research through his innovative work on genetic mutations. His research focuses on the MKK4 gene, which plays a crucial role in various human cancers.
Latest Patents
William L. Perry, III holds a patent for "Specific mutations of map kinase 4 (MKK4) in human tumor cell lines." This invention relates to mutations in the MKK4 gene in human cancers and their use in the diagnosis and prognosis of human cancer. Specific mutations in the MKK4 gene associated with breast, pancreatic, colorectal, and testicular cancers have been identified. The invention also encompasses therapies for human cancers with MKK4 mutations, including gene therapy, protein replacement therapy, and protein mimetics. Additionally, it relates to the screening of drugs for cancer therapy.
Career Highlights
Perry is currently employed at Myriad Genetics, Inc., where he continues to advance research in genetic mutations and their implications for cancer treatment. His work has the potential to significantly impact the diagnosis and therapy of various cancers.
Collaborations
Some of his notable coworkers include David H. Teng and Sean V. Tavtigian, who have collaborated with him on various research projects.
Conclusion
William L. Perry, III's contributions to cancer research through his patent on MKK4 mutations highlight the importance of genetic studies in developing effective cancer therapies. His work at Myriad Genetics, Inc. continues to pave the way for advancements in cancer diagnosis and treatment.